Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Ovulation Induction”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,027 records · Page 57Linked to original sources

[Induction of ovulation by a luteinizing hormone releasing hormone pump. Principles, indications and results].

A new treatment of hypothalamic amenorrhea is based mainly on Knobil's data demonstrating the physiological pulsatile secretion of GnRH. This hormone can be administered intravenously in a chronic intermittent (pulsatile) fashion. Nine women suffering from hypothalamic amenorrhea received 1 pulse of GnRH 5 to 20 micrograms every 90 minutes via a portable infusion pump. Nine pregnancies were induced after a mean 1.5 cycle. Three precocious miscarriages occurred. At this moment two children are born and four other pregnancies are undelivered. Venous tolerance was excellent, except in one patient who developed repeated venitis. Pulsatile administration of GnRH is very effective in inducing ovulation without risk of hyperstimulation frequently observed with HMG-hCG.

Abortion, Spontaneous↗

Induction of ovulation with pulsatile LHRH.

Seven patients with primary or secondary hypogonadotropic amenorrhea and hypothalamic deficits were given LHRH intravenously by a pulsatile pump (Zyklomat-Ferring). 25 treatment cycles were studied: eighteen of them were ovulatory, only one was to be interrupted because of ovarian hyperstimulation. None of the patients had any side effects caused either by the drug or by the means of delivery. The low incidence of multiple pregnancies, the tolerability and the ovulatory response make pulsatile infusion of LHRH a valid alternative to other methods for this kind of subject.

Adult↗

Induction of ovulation with cyclophenyl.

The results of 495 cycles of treatment with Cyclophenyl given to 286 women suffering from amenorrhea, oligomenorrhea or persistent anovulation are reported. In 61 cases the drug solved the problems of infertility, with a success rate of 43%. The over-all success rate was 58% (288 ovulatory cycles produced in 495 treatment cycles). In detail:--in cases of prolonged amenorrhea, with plasma estradiol levels lower than 50 pg/ml, the positive results were only 15%;--in cases of short-term amenorrhea, with plasma estradiol levels lower than 50 pg/ml, the success rate was only 18%;--in cases with prolonged amenorrhea but with plasma estradiol levels higher than 50 pg/ml, the success rate was 43%;--in cases of short-term amenorrhea with plasma estradiol levels higher than 50 pg/ml, the success rate was 68%;--in cases of oligomenorrhea and of persistent anovulation, the success rate was 72%.

Amenorrhea↗

Induction of ovulation in cyclic mares by administration of a synthetic prostaglandin, fenprostalene, during oestrus.

Fenprostalene (250 micrograms) or saline was given at 60 h after the onset of oestrus in alternate oestrous periods to 8 mares for 4 cycles. Onset of oestrus and stage of cycle were determined by daily teasing, palpation and ultrasonography until time of treatment when follicular development was monitored at 12-h intervals to confirm ovulation. Serum progesterone concentrations were monitored daily. The interval from treatment to ovulation was significantly decreased (41.25 vs 73.50 h; P = 0.001) as was the duration of oestrus (5.63 vs 6.88 days; P = 0.005). There was no significant difference in the duration of dioestrus (15.88 vs 15.75 days; P = 0.94). There were no significant differences between serum progesterone concentrations at onset of oestrus, at treatment or at examination before ovulation. Follicular size was not significantly different at onset of oestrus or before ovulation. There was no statistically significant difference in follicle size at the time of treatment when a possible horse effect was controlled for, although a significant difference (P less than 0.05) was seen when the horse effect was not taken into account. Clinically, 81% of treated mares had ovulated by 48 h after treatment compared to 31% of the control mares (chi 2; P less than 0.025). The results demonstrate that fenprostalene can effectively hasten time of ovulation in cyclic mares.

Animals↗

Induction of ovulation in anestrous mares with pulsatile administration of gonadotropin-releasing hormone.

Four seasonally anestrous mares (Standardbred), housed under a nonstimulatory photoperiod of 8 hours light:16 hours dark, were administered gonadotropin-releasing hormone (GnRH) in a pulsatile pattern (50 or 250 micrograms of GnRH/hour) for 8 to 18 days during February and March 1985. Treatment with GnRH, irrespective of dose or month, induced an increase in serum luteinizing hormone from a mean pretreatment value typical of anestrus (0.58 +/- 0.02 ng/ml +/- SE) to 10.84 +/- 1.27 ng/ml on day 8 of GnRH treatment. Ovulation in the 4 mares occurred 8.8 +/- 0.7 days after the initiation of pulsatile GnRH administration. In each instance, ovulation was followed by a functional corpus luteum, as indicated by a luteal phase (defined as the number of days on which serum levels of progesterone were greater than 1.0 ng/ml) which lasted 14.5 +/- 0.6 days. These results indicate that infusion of GnRH in a pulsatile pattern is effective in inducing follicular development and ovulation in anestrous mares in the absence of a stimulatory photoperiod.

Anestrus↗

[Induction of ovulation using pulsatile GnRH administration to infertile females].

6 infertile women with primary or secondary amenorrhoea or anovulation, who failed to ovulate after clomiphene and HMG/HCG treatment, underwent 11 treatment cycles with pulsatile GnRH therapy using a portable pump. Normal ovulation occurred in 9 out of 11 treatment cycles; the luteal phase was normal in 6 cycles. One woman conceived in the second treatment cycle.

Adult↗

[Induction of ovulation in 1985].

There are many methods that can be used to induce ovulation when there is a fault in ovulation in patients who have normal prolactin levels. These are: Bringing the weight to a normal level. Giving Clomiphene. Giving Tamoxifen. Giving cyclofenil and bromocriptine, which really have no more effect than giving a placebo. Giving gonadotrophins in a classical way. This is very useful where there is hypogonadic amenorrhoea but much less useful when the failure of ovulation occurs with normal gonadic function. It is accompanied by a risk of multiple pregnancies and of hyperstimulation, which should be monitored by ultrasound very strictly so that it cannot become too serious. The use of purified FSH which theoretically should be more adequate, at least in cases where the gonadic function is normal in spite of failure of ovulation. Pulsatile administration of LHRH, which in cases of hypothalamic amenorrhoea carries less total risk than giving gonadotrophins. Finally, wedge resection of the ovaries which is reversed for polycystic ovaries that are larger than normal in size, and allied methods. The first choice for hypogonadic hypothalamic amenorrhoea would seem to be the LHRH pump; and for failure of ovulation with normal gonadic function Clomiphene or Tamoxifen. When anti-oestrogens fail to correct these latter cases one can choose according to the case between gonadotrophins, choosing if possible pure FSH, and/or wedge resection. In the last resort in these cases the LHRH pump can be used. The frequent failure of these methods show that perhaps it is possible to create a hypogonadotrophic hypogonadism by giving agonists for a long time or antagonists to LHRH in such a way that a second attempt can be made to induce ovulation using gonadotrophins in better conditions of efficacy and safety.

Amenorrhea↗

Plasma estradiol window and urinary estriol glucuronide determinations for monitoring menotropin induction of ovulation.

The plasma estradiol response is maximal 8--10 hours following mentropin injection. To obtain closer control, a menotropin protocol using 5 PM--8 PM injections and 8 AM blood sampling with a plasma estradiol window of 1000--2000 pg/ml was evaluated with simultaneous calibration of a urinary estriol glucuronide radioimmunoassay. One hundred twenty-eight paired urine and plasma samples were assayed in 48 cycles. In 26 cycles with paired samples on the day of human chorionic gonadotropin (hCG) injection, there were no cases of severe hyperstimulation, 2 cases of moderate hyperstimulation, and 11 pregnancies (42% of cycles given hCG). A window of between 40 and 100 micrograms/day of urinary estriol glucuronide corresponded to the 1000--2000 pg/ml plasma estradiol window by regression analysis. The pregnancy and hyperstimulation rates were compared with those observed in protocols previously published. Radioimmunoassay of urinary estriol glucuronide is faster and simpler than radioimmunoassay of plasma estradiol.

Abortion, Spontaneous↗